Press Release
How Bitrix24 Makes Cross-Department Collaboration Faster and Easier
Bitrix24 streamlines teamwork by connecting departments in a single workspace for file sharing, task management, and real-time communication. Teams stay aligned, projects move faster, and your company structure stays intact. Read More
Press Release
Samsung Customer Care Team to be Featured on 'Trending Today' on Fox Business for Its Commitment to Innovation, Expert Training, and Customer-First Solutions
The acclaimed television series will spotlight how Samsung is redefining customer care through advanced training programs, cutting-edge solutions, and a people-first approach. Read More
Press Release
New 'Trending Today' Episode on Fox Business Spotlights Leaders in Customer Care Innovation, Luxury Homebuilding, and Employee Legal Protection
Episode airing Saturday, November 23 at 5:30 p.m. EST features Samsung Electronics America, Bradford Custom Homes and Remodeling, and LegalEASE Read More
Press Release
Horizon Aircraft's VTOL Targets Flight Operations in Icing Conditions that Ground Most Helicopters
The Cavorite X7 is designed to fly safely in clouds and known icing conditions at faster speeds and lower operating costs than helicopters, aiming for undisrupted flight operations worldwide Read More
Press Release
XCF Global Welcomes Growing Momentum for Sustainable Aviation Fuel Adoption in the United States
Policy Momentum: Federal and state policy alignment is accelerating nationwide SAF adoption Market Opportunity: U.S. SAF market projected at $7 billion by 2030, with a $25 billion global opportunity Strategic Investment: $350 million invested in the New Rise Reno facility, advancing America's push to decarbonize aviation Read More
Press Release
Altamira Therapeutics Announces Certification of Bentrio Nasal Spray under Medical Device Regulation
Conformity with stringent new EU regulations for medical devices confirmed Allows for commercialization of Bentrio in EU member states; facilitates regulatory approval in various other countries Major milestone in international growth strategy Read More
Press Release
In Support of Possible Expedited Approval Pathway for Crofelemer for Treatment of Microvillus Inclusion Disease (MVID), Jaguar Health Submits Amended Protocol to FDA for Ongoing Placebo-Controlled Clinical Trial
Crofelemer can potentially extend lives of MVID patients - infants and children who face the lethal natural history of the disease Parenteral support reduction of up to 37% is groundbreaking; No approved treatments exist for MVID in any region Read More
Press Release
LegalEASE Featured on 'Trending Today' TV Series on Fox Business for Pioneering Legal Benefits That Empower Employees Nationwide
The acclaimed television series will highlight how LegalEASE is setting a new standard in legal benefits through innovation, education, and a national network of top-tier attorneys. Read More
Press Release
Ondas Announces $35 Million Strategic Investment in Performance Drone Works ("PDW") to Expand Production of Next Generation of Combat Robotics
PDW is a leading manufacturer of combat robotics deployed by customers across every branch of the United States military PDW's Drone Factory 01, a 90,000 sq. ft. manufacturing facility in Huntsville, Alabama has capacity to produce up to 100,000 NDAA-compliant advanced drone systems, valued at approximately $1 Billion, per year Ondas' investment will be deployed to scale production, significantly increase engineering headcount, and secure supply of NDAA-compliant domestically sourced components Read More
Press Release
Moderna Secures $1.5 Billion Five-Year Credit Facility from Ares Management
Non-dilutive financing from premier lender bolsters strong balance sheet and provides increased flexibility Company reiterates 2025 financial guidance provided on 3Q25 earnings call and targets cash breakeven by 2028 Read More
Press Release
Moderna Analyst Day Highlights Pipeline Progress and Business Strategy Updates
Announces three-year business strategy and commercial growth drivers, targeting up to 10% revenue growth in 2026 Expects to expand seasonal vaccine franchise from three to up to six approved products by 2028 Targets readouts from nine ongoing Phase 2 and Phase 3 clinical studies in its oncology pipeline, including three Phase 3 programs for intismeran autogene Further improves 2026 and 2027 expected GAAP operating expenses by approximately $0.5 billion each year on path to targeted cash breakeven in 2028 Read More
Press Release
